Replies to post #2758 on Adamis Pharmaceuticals Corp (ADMP)

[66Mustang]

I think it goes WAY beyond this in potential. This cut off Virus replication. Vaccination has long been known as the only real method to fight viral infection; antibiotics target bacterial infections, not viral. Viruses can have various medications to treat symptoms but only recently has anything been created to try to rein in the actual virus; it was typically allowed to run its course and just try to keep a patient as comfortable as possible. But if Tempol can prove effective in a broad spectrum or full spectrum of virus replication, think of the potential! As an example, HIV is a virus. As are Chickenpox, herpes, shingles, mumps, measles, etc. Is the future of Tempol so wide-ranging? Definitely possible, with trials an approvals for efficacy against each, since safety is already proven.

NOW what should this stock be worth??


Message in reply to:
If interim is stellar,Tempol could get used for many strains maybe....

but what I see down the road..better than Covid use,is decades of use with an extended label for the ordinary FLU or Cold..Think about that for a second..Tic Toc..lungs are lungs if the safety is there and it is used to clear lungs from infection..Much still in the air of course..

Thanks Roll